• About Us
  • Activity
  • Advertising
  • Books
  • Business
  • Contact
  • Dashboard
  • EB5
  • Entertainment
  • feedback
  • Forgot Your Password?
  • Government
  • Home
  • Home 20723
  • Interviews
  • Login
  • Members
  • Meme generator
  • National
  • Nevada
  • Nevada News and Views
  • Newsmax
  • NN&V Ads
  • Opinion
  • Pick a New Password
  • Politics
  • Polls
  • Privacy Policy
  • Profile
  • Recent comments by me
  • Recent comments on my posts
  • Register
  • Submit post
  • Subscribe
  • Subscription Confirmation
  • Survey
  • Survey
  • Terms of Service
  • Today’s Top 10
  • Travel
  • Travel
  • Travel
  • Welcome!
  • Yop Poll Archive
Nevada News and Views
  • About Us
  • Contact
  • More
    • Opinion
  • Facebook

  • Twitter

  • Pinterest

  • RSS

Featured Article

Kaiser Family Foundation Study Highlights Need for Patent Reform to Rein-In Big Pharma’s Price Gouging

Kaiser Family Foundation Study Highlights Need for Patent Reform to Rein-In Big Pharma’s Price Gouging
Chuck Muth
October 22, 2019

(Coalition Against Patent Abuse) – A new report from the Kaiser Family Foundation (KFF) examines the rising cost of Medicare Part D drugs and found that Big Pharma has jacked up the price of key prescription drugs well above the rate of inflation between 2016 and 2017.

 

Among the worst offenders, according to the KFF report, are drugs like Humira and Lyrica which saw their owners AbbVie and Pfizer hike prices by 13.2 and 15.7 percent above the inflation rate, respectively.

 

Companies like AbbVie and Pfizer are able to gouge patients because they have established effective monopolies by abusing the American patent system through the use of dishonest tactics like patent thicketing and product hopping.  For example, Humira, earned Abbvie over $20 billion in sales worldwide last year even though Humira’s patents were set to expire in 2016, which should have been when less costly generic versions would come to the market.  However, as that expiration date approached, Abbvie suddenly started applying for new patents.  In total AbbVie filed 247 patent applications, almost half of these patent applications were filed after the first patent expired.  It is inconceivable that somehow all these applications represent significant new “inventions” that are worthy of new patents and new 20-year monopolies. 

 

This report reinforces what CAPA has been telling lawmakers, that Big Pharma’s rampant abuse is hurting American patients and must be stopped.

 

Read more on how ending Big Pharma’s patent abuse will result in more affordable medications and treatments for America’s patients HERE.

 

Check out KFF’s full analysis HERE.

The Coalition Against Patent Abuse are healthcare providers, consumer groups, patient advocacy organizations, free market advocates, employers, and others fighting abuses of the patent system that can extend government-granted monopolies that illegitimately keep drug prices high for years, or even decades. Our members include the following groups and organizations: America’s Health Insurance Plans, Association for Accessible Medicines, Blue Cross Blue Shield Association, Campaign for Sustainable Rx Pricing, Citizen Outreach, Consumer Action, Innovation Defense Foundation, Institute for Liberty, Kaiser Permanente, Knowledge Ecology International, Lincoln Network, Niskanen Center, R Street Institute, SEIU, Society for Patient Centered Orthopedics, and U.S. Public Interest Research Group.

Prev postNext post

Related Items
Featured Article
October 22, 2019
Chuck Muth

Related Items

More in Featured Article

Federal court rules Miranda rights don’t apply to civil immigration arrests

The Center SquareNovember 28, 2023
Read More

Making Elections Squeaky Clean: Pigpen Project Rooting Out Bad Registrations

Chuck MuthNovember 25, 2023
Read More

How Sad that We Have to Look South for Happy News

Chuck MuthNovember 20, 2023
Read More

Response to Nikki Haley’s Attack on Free Speech…with a Twist

Chuck MuthNovember 16, 2023
Read More

Report: Mountain states among ‘most free’ in North America

The Center SquareNovember 9, 2023
Read More

The 3 Questions You Should Ask Every Candidate You Run Into

Chuck MuthNovember 6, 2023
Read More
Scroll for more
Tap

Subscribe Free By Email

Looking for the best in breaking news and conservative views? Let Chuck do all the work for you! Subscribe to his FREE "Muth's Truths" e-newsletter.

* indicates required
Nevada News and Views
Nevada News & Views is an educational project of Citizen Outreach Foundation, a non-partisan IRS-approved 501(c)(3) organization. It is not associated or affiliated with any political party or group. Nevada News & Views is accessible by the public at no cost. It funds its operations through tax-deductible contributions from donors and supporters and does not accept government money or grants.

TAGS

Featured Article Muths truth

Copyright © 2023 Citizen Outreach | Maintained by VirtualAlly

Online privacy law takes effect in Nevada
Citizen Outreach Opposes APEX Act’s Price-Setting Over Aluminum Reference Prices